ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

28,401Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 61

$1.64M Total Retail Price of All Prescriptions

Rank: 1 out of 61

655 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 655 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

13% of this provider’s 655 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 24,908 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 956 868 1 3
WARFARIN SODIUM 875 809 2 11
FUROSEMIDE 858 769 3 4
OMEPRAZOLE 835 752 4 5
METOPROLOL TARTRATE 787 728 5 8
JANTOVEN 671 656 6 57
DONEPEZIL HCL 637 609 7 19
NAMENDA 603 565 8 36
HYDROCODONE-ACETAMINOPHEN 598 549 S3 9 7
ALBUTEROL SULFATE 557 468 10 74
LISINOPRIL 528 468 11 2
POTASSIUM CHLORIDE 518 396 12 14
MIRTAZAPINE 449 429 13 43
CEFTRIAXONE 446 415 10 14 86
QUETIAPINE FUMARATE 408 393 15 56
SERTRALINE HCL 406 386 16 22
AMLODIPINE BESYLATE 368 365 17 6
TRAZODONE HCL 348 313 18 34
SIMVASTATIN 331 281 19 1
CYMBALTA 329 269 20 78
METFORMIN HCL 328 272 21 9
KLOR-CON M20 313 301 22 46
TRAMADOL HCL 309 276 23 15
GABAPENTIN 304 270 24 12
CLOTRIMAZOLE-BETAMETHASONE 292 281 25 98
IPRATROPIUM-ALBUTEROL 282 221 26 106
LACTULOSE 279 201 27 95
EXELON 268 237 28 101
CITALOPRAM HBR 258 214 29 18
LANTUS 251 184 30 39
RISPERIDONE 239 189 31 65
DIGOXIN 226 223 32 54
GLIPIZIDE 221 177 33 70
GLYBURIDE 207 165 R 34 60
CLONIDINE HCL 206 178 35 47
DIVALPROEX SODIUM 205 167 36 64
ESCITALOPRAM OXALATE 200 170 37 89
POLYETHYLENE GLYCOL 3350 186 161 38 91
BENZTROPINE MESYLATE 183 127 R 39 134
ATENOLOL 183 171 39 16
LEVOFLOXACIN 171 158 41 139
PAROXETINE HCL 167 141 42 66
OLANZAPINE 167 152 42 108
TAMSULOSIN HCL 162 140 44 35
ISOSORBIDE MONONITRATE ER 156 152 45 41
NOVOLIN R 154 148 46 103
DEXTROSE WITH SODIUM CHLORIDE 149 148 10 47 150
PREDNISONE 148 133 48 45
SEROQUEL 148 144 48 119
LEVETIRACETAM 146 93 50 116
HALOPERIDOL 139 118 51 109
LIDODERM 138 121 52 131
NOVOFINE AUTOCOVER 135 135 53 158
CLOZAPINE 134 51 54 93
FENTANYL 132 116 S2 55 76
FAMOTIDINE 131 110 56 84
NYSTATIN 119 97 57 122
SODIUM CHLORIDE 119 110 57 129
SPIRONOLACTONE 115 96 59 53
SSD 115 111 59 170
HYDROCHLOROTHIAZIDE 110 83 61 10
DIOVAN 109 109 62 59
RANITIDINE HCL 108 97 63 52
HYDRALAZINE HCL 106 106 64 90
IPRATROPIUM BROMIDE 104 103 65 173
METOPROLOL SUCCINATE 104 104 65 25
LIDOCAINE HCL 102 95 67 175
CEFUROXIME 102 95 67 145
CLOPIDOGREL 102 95 67 33
NOVOLIN 70-30 101 101 70 176
ABILIFY 100 60 71 125
RAMIPRIL 100 74 71 177
METOCLOPRAMIDE HCL 99 83 73 179
DOXYCYCLINE HYCLATE 96 83 74 117
SUCRALFATE 89 81 75 128
PHENYTOIN SODIUM EXTENDED 86 71 76 105
FLUOXETINE HCL 86 86 76 85
NITROGLYCERIN PATCH 84 84 78 184
DILTIAZEM 24HR CD 84 83 78 154
CIPROFLOXACIN HCL 84 69 78 48
ALLOPURINOL 84 83 78 30
NOVOLOG MIX 70-30 FLEXPEN 83 83 82 185
ATORVASTATIN CALCIUM 82 80 83 13
CARAFATE 82 39 83 186
RIVASTIGMINE 81 55 85 187
LEXAPRO 79 66 86 189
CARVEDILOL 78 63 87 26
VALPROIC ACID 77 50 88 190
ZOLPIDEM TARTRATE 76 68 89 24
NYSTOP 75 72 90 159
PRAVASTATIN SODIUM 75 71 90 17
NOVOLIN N 74 70 92 192
CARBIDOPA-LEVODOPA 74 74 92 109
DIVALPROEX SODIUM ER 72 15 94 118
SEROQUEL XR 72 36 94 194
DILANTIN 71 45 96 196
OXYBUTYNIN CHLORIDE ER 70 67 97 63
MEGESTROL ACETATE 69 66 R 98 155
ADVAIR DISKUS 69 59 98 68
MUPIROCIN 69 68 98 198
SULFAMETHOXAZOLE-TRIMETHOPRIM 69 64 98 73
INVEGA 68 32 102 199
NOVOLOG FLEXPEN 67 66 103 140
XOPENEX 67 67 103 200
VERAPAMIL ER 67 67 103 100
PLAVIX 66 51 106 67
IBUPROFEN 66 43 106 55
PHENYTOIN 65 53 108 201
TORSEMIDE 61 60 109 161
ISOSORBIDE DINITRATE 59 54 110 212
AZITHROMYCIN 58 56 111 27
LYRICA 58 52 111 50
TRIAMCINOLONE ACETONIDE 56 55 113 216
FINASTERIDE 56 55 113 130
CARBAMAZEPINE 54 0 115 162
VENLAFAXINE HCL ER 53 53 116 133
LOSARTAN POTASSIUM 52 49 117 28
SPIRIVA 51 49 118 61
BACLOFEN 50 37 119 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.